Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Mol Biol Res Commun ; 12(2): 57-62, 2023.
Article in English | MEDLINE | ID: mdl-37520467

ABSTRACT

Neovascular age-related macular degeneration (nAMD) is a progressive ocular disease, responsible for central visual loss and blindness in elderly population. Increase data demonstrate that genetic factors play an important role in pathogenesis process of this disease. The aim of this study is to investigate the association between rs3732378 polymorphism in CX3CR1 gene and nAMD in a sample of Algerian patients. This case-control study consisted of 72 patients with nAMD and 124 control subjects. DNA of participants was extracted using salting out method. Genotyping was carried out using the TaqMan real-time polymerase chain reaction method. Statistical analysis was performed by SPSS.21.0. The prevalence of the risk genotype AA was higher in the nAMD group than in control group (OR=5.02, 95% CI=1.44-17.4, P=0.011). In our sample of Algerian patients, the rs3732378 polymorphism is associated with nAMD. This result may support the role of CX3CR1 gene in the pathogenesis of nAMD.

2.
Ann Biol Clin (Paris) ; 80(5): 413-422, 2022 09 01.
Article in English, French | MEDLINE | ID: mdl-36453747

ABSTRACT

Background: Increasing evidence shows that genetic and environmental factors can influence neovascular age-related macular degeneration (nAMD) risk. The aim of this study was first to analyse the association of insertion/deletion polymorphism in VEGF gene and environmental factors with the risk of nAMD, and then to investigate whether these factors have an impact on the age of onset of nAMD in a sample of the Algerian population. Methods: Seventy two patients with nAMD and one hundred twenty-four controls were recruited; standardized questionnaire was used to collect information regarding underlying systemic diseases and important environmental factors. Genotyping of VEGF (I/D) SNP was conducted using PCR-based assay approach, and statistical analyses were conducted using IBM SPSS statistics 21. Results: A significant association was reported of age (p < 0.05), smoking (p = 0.02), alcohol (p < 0.01), hypertension (p = 0.04), hyperlipidaemia (p = 0.008) and thyroid disease (p = 0.03) with nAMD. Also, Thyroid disease may have a role in accelerating the development of nAMD in an earlier age in our sample (p < 0.001). No association was found between the VEGF ­ 2549 I/D genotype and the presence of nAMD (p = 0.27), neither with the age of onset of nAMD (p = 0.21). Conclusion: Our results suggest that age, smoking, alcohol, hypertension, hyperlipidaemia and thyroid diseases are possible risk factors that could increase the risk of nAMD in a sample of Algerian population. In addition, VEGF ­ 2549 I/D might not be associated with the risk of nAMD development. Finally, thyroid disease may accelerate the development of nAMD in an earlier age.


Introduction: Un nombre croissant de preuves montrent que les facteurs génétiques et environnementaux peuvent influencer le risque de la forme néovasculaire de la dégénérescence maculaire liée à l'âge (DMLAn). L'objectif de cette étude était d'abord d'analyser l'association du polymorphisme d'insertion/délétion dans le gène VEGF et des facteurs environnementaux avec le risque de la DMLAn, puis d'étudier si ces facteurs ont un impact sur l'âge d'apparition de cette maladie dans un échantillon de population algérienne. Méthodes: Soixante-douze patients atteints de la DMLA et 124 témoins ont été recrutés ; un questionnaire standardisé a été utilisé pour recueillir des informations concernant les maladies systémiques sous-jacentes et les facteurs environnementaux importants. Le génotypage du SNP VEGF (I/D) a été réalisé par une l'approche de PCR standard, et les analyses statistiques ont été réalisées à l'aide du logiciel IBM SPSS statistics 21. Résultats: Une association significative a été rapportée entre l'âge (p < 0,05), le tabagisme (p = 0,02), l'alcool (p < 0,01), l'hypertension (p = 0,04), l'hyperlipidémie (p = 0,008) et les maladies thyroïdiennes (p = 0,03) avec la DMLAn. Les maladies thyroïdiennes peuvent jouer un rôle dans l'accélération du développement de la DMLAn à un âge plus précoce dans notre échantillon (p < 0,001). Aucune association n'a été trouvée entre le génotype VEGF ­ 2549 I/D et la présence de la DMLA néovasculaire (p = 0,27), ni avec l'âge d'apparition de cette pathologie (p = 0,21). Conclusion: Nos résultats suggèrent que l'âge, le tabagisme, l'alcool, l'hypertension, l'hyperlipidémie et les maladies thyroïdiennes sont des facteurs de risque possibles qui pourraient augmenter le risque de la DMLA néovasculaire. De plus, le VEGF ­ 2549 I/D pourrait ne pas être associé au risque de développement de la DMLA. Enfin, les maladies thyroïdiennes pourraient accélérer le développement de la DMLAn à un âge plus précoce.


Subject(s)
Hypertension , Macular Degeneration , Humans , Vascular Endothelial Growth Factor A/genetics , Algeria/epidemiology , Vascular Endothelial Growth Factors , Polymorphism, Genetic , Ethanol , Macular Degeneration/etiology , Macular Degeneration/genetics
3.
Mol Biol Res Commun ; 11(2): 105-111, 2022 Jun.
Article in English | MEDLINE | ID: mdl-36059931

ABSTRACT

Increasing evidence shows that polymorphisms in CFI and ARMS2 genes can influence exudative age-related macular degeneration (nAMD) risk. The aim of this study was to assess the role of CFI rs10033900 and ARMS2 rs3750846 polymorphisms in susceptibility to nAMD for the first time in the Algerian population. A total of one hundred twenty four controls and seventy two nAMD cases were included in the present study. Genomic DNA was extracted from venous blood leukocytes. CFI rs10033900 and ARMS2 rs3750846 variants were determined by using the real­time polymerase chain reaction method. Differences in allele and genotype distribution between the cases and controls were tested with adjustment for age by logistic regression analysis. A stratification of case and control groups by age (<65 or ≥65) and by gender (male and female) was also performed. Statistical analyses were done using SPSS21.0. No statistically significant association was observed between CFI rs10033900 and ARMS2 rs3750846 polymorphisms and nAMD risk (p>0.05 for all comparisons). Stratification by age and gender did not show any significant association between these two polymorphisms and nAMD in a sample of the Algerian population. In our study, CFI rs10033900 and ARMS2 rs3750846 polymorphisms did not predispose alone to nAMD in our population. This study is a contribution to the enrichment of the bank data concerning the CFI and ARMS2 genes, reporting, for the first time, the allelic and genotypic frequencies of these genes polymorphisms characterizing the Algerian population.

SELECTION OF CITATIONS
SEARCH DETAIL
...